Financhill
Sell
30

IMDX Quote, Financials, Valuation and Earnings

Last price:
$2.84
Seasonality move :
-2.21%
Day range:
$2.61 - $3.00
52-week range:
$1.92 - $4.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.97x
P/B ratio:
8.00x
Volume:
85.4K
Avg. volume:
114.4K
1-year change:
-9.21%
Market cap:
$81.8M
Revenue:
$1.9M
EPS (TTM):
-$3.53

Earnings Data

Next earnings date for IMDX
Aug 08
2025
Most recent earnings per share
-$0.26
Missed by $0.01
(May 12/2025)
Consensus Estimate
-$0.25
(May 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IMDX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $283.9K -- -- -$0.25 --
08/08/2025 Q2 $292K -- -- -$0.24 --
05/12/2025 Q1 $126.8K $2.1M -$0.26 -$0.25 -$0.01
12/31/2024 Q4 $101.7K $1.5M -$1.93 -- --
09/30/2024 Q3 $168.3K $115K -$0.98 -- --
06/30/2024 Q2 $312.4K $104K -$0.36 -$0.37 $0.01
03/31/2024 Q1 $350K $176K -$1.13 -$0.57 -$0.56
12/31/2023 Q4 $316.7K $314K -$2.07 -- --
09/30/2023 Q3 $312.5K $429K -$0.81 -$0.78 -$0.03
06/30/2023 Q2 $350K $463K -$1.07 -$0.59 -$0.48
03/31/2023 Q1 -- $297K $0.40 -- --
12/31/2022 Q4 -- $274K -$8.03 -- --
09/30/2022 Q3 -- $67K -$1.62 -- --
06/30/2022 Q2 -- $237K -$1.48 -- --
03/31/2022 Q1 -- $380K -$2.20 -- --
12/31/2021 Q4 -- -$1.9M -$7.80 -- --
09/30/2021 Q3 -- $984K -$3.00 -- --
06/30/2021 Q2 -- $2M -$2.40 -- --
03/31/2021 Q1 -- $1.1M -$1.00 -- --
12/31/2020 Q4 -- $503K -$1.80 -- --
09/30/2020 Q3 -- $555K -$2.00 -- --
06/30/2020 Q2 -- $143K -$2.80 -- --
03/31/2020 Q1 -- $16K -$2.60 -- --
12/31/2019 Q4 -- -- -$3.00 -- --
09/30/2019 Q3 -- -- -$2.00 -- --
06/30/2019 Q2 -- -- -$2.07 -- --
03/31/2019 Q1 -- -- -$1.60 -- --
12/31/2018 Q4 -- -- -$2.20 -- --
09/30/2018 Q3 -- -- -$1.40 -- --
06/30/2018 Q2 -- -- -$2.40 -- --
03/31/2018 Q1 -- -- -$2.40 -- --
12/31/2017 Q4 -- -- -$2.60 -- --
09/30/2017 Q3 -- -- -$4.40 -- --
06/30/2017 Q2 -- -- -$2.60 -- --
03/31/2017 Q1 -- -- -$3.20 -- --
12/31/2016 Q4 -- -- -$2.20 -- --
09/30/2016 Q3 -- -- -$2.00 -- --
06/30/2016 Q2 -- -- -$2.00 -- --
03/31/2016 Q1 -- -- -$2.40 -- --
12/31/2015 Q4 -- -- -$2.80 -- --
09/30/2015 Q3 -- -- -$1.90 -- --

Insight Molecular Diagnostics Earnings Questions

  • How Much did Insight Molecular Diagnostics Generate in Revenue Last Quarter?

    Insight Molecular Diagnostics reported $2.1M worth of top line sales in its most recent quarter.

  • Did Insight Molecular Diagnostics Beat Earnings Last Quarter?

    Insight Molecular Diagnostics announced earnings per share of -$0.26 which represents a miss of analyst forecast a -$0.25 per share.

  • Is Insight Molecular Diagnostics Profitable?

    Insight Molecular Diagnostics reported $1.3M that represents $0.05 per share over the last quarter.

  • What is the Analyst Consensus for Insight Molecular Diagnostics EPS Next Year?

    Insight Molecular Diagnostics's earnings are forecast to decrease from -$4.66 per share to -$0.99 per share next year representing a decrease of -78.76%.

  • When is Insight Molecular Diagnostics's Earnings Date?

    Insight Molecular Diagnostics's next earnings date is August 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Oklo Stock Double?
Will Oklo Stock Double?

Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…

Why a $5 Stock Is Suddenly a Cash Machine
Why a $5 Stock Is Suddenly a Cash Machine

If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…

Is Roku Stock Undervalued Now?
Is Roku Stock Undervalued Now?

At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 14

MiNK Therapeutics [INKT] is down 36.03% over the past day.

Buy
51
NEGG alert for Jul 14

Newegg Commerce [NEGG] is down 26.42% over the past day.

Buy
68
ATRO alert for Jul 14

Astronics [ATRO] is down 1.02% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock